|
|
|
|
| 专题 |
最后回覆 |
昵称 |
内容 |
| 兆科眼科有限公司 |
2022-03-28T16:11 |
财经茄呢啡 |
兆科眼科在干眼症、近视及老花三大领域，已有产品完成三期临牀研究或在进行三期临牀研究中；研发亦兼顾角膜修复，并由眼表症状，延伸到眼底如湿性老年黄斑部病变、糖尿病引发眼疾等方面部署。 |
| 兆科眼科有限公司 |
2022-03-28T16:11 |
财经茄呢啡 |
兆科眼科（6622）今年内有望推出首款针对青光眼药物，将开始录得收入。他提到，随着集团研发多款药物进入三期临牀研究阶段，料今年研发费用会大幅上升，但手上资金足够应付未来两至三年临牀研究所需。 |
|
|
|
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window